# Economic Evaluation of Rivastigmine in Patients with Parkinson??s Disease Dementia

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/economic-evaluation-of-rivastigmine-in-patients-with-parkinson-s-disease/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Andrew R. Willan,Ron Goeree,Eleanor Pullenayegum,Christopher R. McBurney,Gordon Blackhouse |
| Citations | 17 |
| DOI | 10.2165/00019053-200624010-00008 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2084273456 |
| PMID | 16445306 |
| Type | article |
| Year | 2006 |

## Paper authors

- [Christopher R. McBurney](https://scholariq.org/researchers/christopher-r-mcburney/)

## Paper journal

- [PharmacoEconomics](https://scholariq.org/journals/pharmacoeconomics/)

## Paper primary topic

- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)

## Paper topics

- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Parkinson's Disease and Spinal Disorders](https://scholariq.org/topics/parkinson-s-disease-and-spinal-disorders/)
- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.